Pillstats
Rx only · Tablet · Oral

Ibuprofen And Famotidine

Famotidine + Ibuprofen

8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US9 NDCs
8 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)4278
US makers8 labelers
Packages19
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.272$0.543$0.815$1.09Dec 2025Mar 2026Jul 2026
$0.845
Latest avg · Jul 22, 2026
+23%
Since Dec 17, 2025
8
Active US suppliers
47%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2565127681.0K2025 Q12025 Q22025 Q32025 Q42026 Q1
446
Rx · 2026 Q1
35K
Units dispensed
-50%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it8 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Advanced Rx of Tennessee, LLCunknown6SUPPLYING
ADVANCED RX PHARMACY OF TENNESSEE, LLCunknown3SUPPLYING
Ascent Pharmaceuticals, Inc.unknown3SUPPLYING
PHOENIX RX LLCunknown3SUPPLYING
Viona Pharmaceuticals Incunknown1SUPPLYING
Zydus Lifesciences Limitedunknown1SUPPLYING
Camber Pharmaceuticals, Inc.unknown1SUPPLYING
Par Health USA, LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.